Inventor · disambiguated record
Monika Krampert
Also filed as: KRAMPERT MONIKA
5 granted patents·5 pending applications·5 citations·filing 2014–2025
71Inventor score
Files withMINA THERAPEUTICS LTD4Neurovision Pharma GmbH4FLAGSHIP PIONEERING INNOVATIONS VII LLC1HOFFMANN LA ROCHE1
Top patents by PatentIndex Score
10 records- 0181US10912790B2C/EBP alpha saRNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2016·Granted Feb 9, 2021·2 cites·23 claims
- 0276US11213541B2Antisense-oligonucleotides as inhibitors of TGF-R signalingNeurovision Pharma GmbH·Filed 2015·Granted Jan 4, 2022·2 cites·5 claims
- 0375US11965163B2HNF4a saRNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2021·Granted Apr 23, 2024·0 cites·12 claims
- 0467US11162099B2HNF4A saRNA compositions and methods of useMINA THERAPEUTICS LTD·Filed 2018·Granted Nov 2, 2021·0 cites·4 claims
- 0565US2022143071A1Antisense-oligonucleotides as inhibitors of tgf-r signalingNeurovision Pharma GmbH·Filed 2021·Application pending·0 cites
- 0663US10363266B2Antisense-oligonucleotides as inhibitors of TGF-R signalingNeurovision Pharma GmbH·Filed 2015·Granted Jul 30, 2019·1 cites·5 claims
- 0760US2021187007A1C/ebp alpha sarna compositions and methods of useMINA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0854US2019314401A1Antisense-oligonucleotides as inhibitors of tgf-r signalingNeurovision Pharma GmbH·Filed 2019·Application pending·0 cites
- 0946US2025263702A1Rnai agents targeting cideb and related methodsFLAGSHIP PIONEERING INNOVATIONS VII LLC·Filed 2025·Application pending·0 cites
- 1042US2015368642A1Lna oligonucleotide carbohydrate conjugatesHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Monika Krampert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →